Stifel analyst Nathan Jones lowered the price target on Crane (NYSE: CR) to $200.00 (from $201.00) while maintaining a Hold rating.

The analyst commented, "Investor focus has been on guidance with many we’ve spoken to believing 1Q26 and full year 2026 guidance was excessively conservative in multiple parts of the business and looking for accelerated synergy generation from PSI. In our view, PSI was not core for Baker Hughes and likely has considerable room for internal improvement as CBS is deployed into the businesses to drive growth and margin expansion, but will take time to work through and renegotiate legacy contracts. Process Flow Technologies, which is primarily valves, will be the business to watch with the potential for deferred capital spending in chemical markets the most likely place, in our view, for Crane to see incremental weakness from the Iran war. MRO in PFT should continue to be solid with industrial output continuing to drive demand for maintenance spending. Aerospace & Advanced Technologies outlook should remain be positive with growth in commercial OEM as Boeing ramps up production, while defense benefits from discrete programs and increased DoD spending in 2026. Conservative commercial aftermarket guidance might prove to be more accurate with potential impacts from higher jet fuel costs."